This 4-lncRNA signature could fairly predict the early recurrence of HCC in TCGA-LIHC cohort, and the prediction performance could be further improved by the combination of the 4-lncRNA signature with TNM stages and AFP. Here, AFP is linked to hepatocellular carcinoma.